Upregulation of lysyl oxidase in vascular smooth muscle cells by cAMP: Role for adenosine receptor activation

Journal of Cellular Biochemistry

Volumn 75, Issue 1, 1999, Pages 177-185

  Ravid, Katya ^a   Smith Mungo, Lynda I ^a   Zhao, Zhiuhu ^a   Thomas, Kathleen M ^a   Kagan, Herbert M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cAMP; Lysyl oxidase; Vascular smooth muscle cells

Indexed keywords

ADENOSINE RECEPTOR; PROTEIN LYSINE 6 OXIDASE;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; ENZYME ACTIVITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; AORTA; CELL COUNT; CELLS, CULTURED; CYCLIC AMP; DNA; ENZYME ACTIVATION; FORSKOLIN; GENE EXPRESSION REGULATION; HUMANS; MUSCLE, SMOOTH, VASCULAR; PROMOTER REGIONS (GENETICS); PROTEIN-LYSINE 6-OXIDASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; RNA, MESSENGER; UP-REGULATION;

ANIMALIA; SIGANUS;

EID: 0033213759     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19991001)75:1<177::AID-JCB18>3.0.CO;2-W     Document Type: Article

References (33)

1. Ando J, Tsuboi H, Korenaga R, Takahashi K, Kosaki K, Isshiki M, Tojo T, Takada Y, Kamiya A. 1996. Differential display and cloning of shear stress-responsive messenger RNAs in human endothelial cells. Biochem Biophys Res Commun 225:347-351.
2. Bedell-Hogan D, Trackman P, Abrams W, Rosenbloom J, Kagan H. 1993. Oxidation, cross-linking, and insolubilization of recombinant tropoelastin by purified lysyl oxidase. J Biol Chem 268:10345-10350.
3. Belardinelli L, Linden J, Berne RM. 1989. The cardiac effects of adenosine. Prog Cardiovasc Dis 32:73-97.
4. Brody J, Kagan HM, Manalo A. 1979. Lung lysyl oxidase activity: relation to lung growth. Am Rev Respir Dis 120:1289-1304.
5. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
6. Dean DC, Blakeley MS, Newby RF, Ghazal P, Hennighausen L, Bourgeois S. 1989. Forskolin inducibility and tissue-specific expression of the fibronectin promoter. Mol Cell Biol 9:1498-1506.
7. Dubey RK, Gillespie DG, Osaka K, Suzuki F, Jackson EK. 1996. Adenosine inhibits growth of rat aortic smooth muscle cells. Possible role of A2b receptor. Hypertension 27:786-793.
8. Ferrer VQ, Hultgardh-Nilsson A, Ringertz NR, Nilson J, Jonzon B. 1992. Adenosine receptors, cAMP accumulation, DNA synthesis in aortic smooth muscle cell cultures of adult and neonatal rats. J Cell Physiol 151:555-560.
9. Frick GP, Lowenstein JM. 1976. Studies of 5′-nucleotidase in the perfused rat heart. J Biol Chem 251:6372-6378.
10. Gacheru SN, Thomas KM, Murray SA, Csiszar K, SmithMungo L, Kagan HM. 1997. Transcriptional and post-transcriptional control of lysyl oxidase expression in vascular smooth muscle cells: effects of TGF-β1 and serum deprivation. J Cell Biochem 64:1-13.
11. Green RS, Lieb ME, Weintraub AS, Gacheru SN, Rosenfield CL, Shah S, Kagan HM, Taubman MB. 1995. Identification of lysyl oxidase and other platelet-derived growth factor-inducible genes in vascular smooth muscle cells by differential screening. Lab Invest 73:476-482.
12. Greenberg ME, Ziff EB. 1984. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311:433-438.
13. Hamalainen ER, Jones TA, Sheer D, Taskinen K, Pihlajaniemi T, Kivirikko K. 1991. Molecular cloning of human lysyl oxidase and assignment of gene to chromosome 5q23.3-31.2. Genomics 11:508-516.
14. Haslam RJ, Davidson MM, Desjardins JV. 1978. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Biochem J 176:83-95.
15. Itoh R, Oka J, Ozawa H. 1986. Regulation of rat heart cytosol 5′-nucleotidase by adenylate energy charge. Biochem J 235:847-851.
16. Jonzon B, Nilsson J, Fredholm BB. 1985. Adenosine receptor-mediated changes in cyclic AMP production and DNA synthesis in cultured arterial smooth muscle cells. J Cell Physiol 124:451-456.
17. Jourdan-Le Saux C, Gleyzal C, Raccurt M, Sommer P. 1997. Functional analysis of the lysyl oxidase promoter in myofibroblast-like clones of 3T6 fibroblast. J Cell Biochem 64:328-341.
18. Kagan HM, Raghavan J, Hollander W. 1981. Changes in aortic lysyl oxidase activity in diet-induced atherosclerosis in the rabbit. Arteriosclerosis 1:287-291.
19. Kreisberg JI, Kreisberg SH. 1995. High glucose activates protein kinase C and stimulates fibronectin gene expression by enhancing a cAMP response element. Kidney Int Suppl 51:83-11.
20. Lee BH, Park RW, Sohn KY, Kim IS. 1997. Antagonistic regulation of protein kinase C-induced stimulation of fibronectin synthesis by cyclic AMP in human lung fibroblasts. Biochem Mol Biol Int 43:383-390.
21. McMahon MP, Faris B, Wolfe L, Brown KE, Pratt CA, Toselli P, Franzblau C. 1985. Aging effects on the elastin composition in the extracellular matrix of cultured rat aortic smooth muscle cells. In Vitro Cell Dev Biol 21:674-680.
22. Ravid K, Doi T, Beeler DL, Kuter DJ, Rosenberg RD. 1991. Transcriptional regulation of the rat platelet factor 4 gene: interaction between an enhancer/silencer domain and the GATA site. Mol Cell Biol 11:6116-6127.
23. Ross R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809.
24. Roy R, Polgar P, Wang Y, Goldstein RH, Taylor L, Kagan HM. 1996. Regulation of lysyl oxidase and cyclooxygenase expression in human lung fibroblasts: interactions among TGF-β, IL-1β, and prostaglandin E. J Cell Biochem 62:411-417.
25. Smith-Mungo LI, Kagan HM. 1998. Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol 16:387-398.
26. Tan RS-P, Taniguchi T, Harada H. 1996. Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression. Cancer Res 56:2417-2421.
27. Tang SS, Trackman PC, Kagan HM. 1983. Reaction of aortic lysyl oxidase with β-aminopropionitrile. J Biol Chem 258:4331-4338.
28. Trackman PC, Bedell-Hogan D, Tang J, Kagan HM. 1992. Post-translational glycosylation and proteolytic processing of a lysyl oxidase precursor. J Biol Chem 267:8666-8671.
29. Tso JY, Sun X-H, Kao T-H, Reece KS, Wu R. 1985. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genetic complexity and molecular evolution of the gene. Nucleic Acids Res 13: 2483-2502.
30. Yamamoto M, Sobue G, Li M, Mitsuma T, Kimata K, Yamada Y. 1994. cAMP-dependent differential regulation of extracellular matrix (ECM) gene expression in cultured rat Schwann cells. Brain Res 653:335-339.
31. Zhao Z, Francis C, Welch G, Loscalzo J, Ravid K. 1997a. Reduced glutathione prevents nitric oxide-induced apoptosis in vascular smooth muscle cells. Biochim Biophys Acta 1359:143-152.
32. Zhao Z, Francis CE, Ravid K. 1997b. An A3-subtype adenosine receptor is highly expressed in rat vascular smooth muscle cells: its role in attenuating adenosine-induced increase in cAMP. Microvasc Res 54:243-252.
33. Ziyadeh FN, Fumo P, Rodenberger CH, Kuncio GS, Neilson EG. 1995. Role of protein kinase C and cyclic AMP/ protein kinase A in high glucose-stimulated transcriptional activation of collagen alpha 1 (IV) in glomerular mesangial cells. J Diabetes Complications 9:255-261.